Information has mysteriously disappeared from the U.S. government's health websites. Here's what we know, and where to find ...
Given these compelling results, Creative Medical Technology plans to advance the development of AlloStem (CELZ-201) for the treatment of late-stage Type 2 Diabetes and explore other potential ...